Howard Levitt, MD

New Heparin Dosing Regimen for Diabetics Undergoing Percutaneous Coronary Intervention

08/01/2008

Gregory Valania , MD;

James R. Wilentz , MD;

Joseph Aragon , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Aslam Khan , MD;

Raj R. Makkar , MD;

Howard Levitt , MD;

Varinder Singh , MD;

Amit Kamra , MD;

Salvatore Rametta , MD;

Unfractionated heparin is the primary anticoagulant administered prior to percutaneous coronary intervention (PCI) to prevent the generation of thrombin at the site of balloon-induced arterial injury and to reduce the thrombogenicity of the...

Unfractionated heparin is the...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Howard Levitt, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products